About VistaPath Biosystems

VistaPath Biosystems has developed an automated tissue grossing platform that streamlines the inspection, inking, and measurement of tissue samples in pathology labs. This technology enhances workflow efficiency and consistency, addressing the challenges of manual processing in anatomic pathology.

```xml <problem> Anatomic pathology labs face challenges with manual tissue grossing, which can lead to inconsistencies, inefficiencies, and potential quality control issues in sample preparation for diagnosis. The manual nature of the process is labor-intensive and prone to human error. </problem> <solution> VistaPath Biosystems offers the Sentinel Platform, an end-to-end digital grossing solution that modernizes pathology labs by delivering higher quality, efficiency, and consistency across critical lab processes. The Sentinel Platform leverages computer vision, automation, and artificial intelligence to streamline the inspection, inking, and measurement of tissue samples. This AI-assisted histology platform enables more complex tissue grossing processes and delivers workflow improvements. The platform supports various specimen types, including excisions, and facilitates seamless remote approvals. </solution> <features> - AI-assisted grossing for improved accuracy and standardization - Computer vision for precise tissue analysis and measurement - Automated inking and imaging for enhanced sample preparation - Digital workflow for streamlined processes and remote approvals - Support for various specimen types, including excisions - Integration with LIS systems for seamless data management </features> <target_audience> The primary target audience includes commercial labs, hospitals, CROs, and life science labs seeking to modernize their pathology workflows and improve the quality and efficiency of tissue grossing. </target_audience> ```

What does VistaPath Biosystems do?

Where is VistaPath Biosystems located?

VistaPath Biosystems is based in Cambridge, United Kingdom.

When was VistaPath Biosystems founded?

VistaPath Biosystems was founded in 2017.

How much funding has VistaPath Biosystems raised?

VistaPath Biosystems has raised 12860000.

Location

Cambridge, United Kingdom

Founded

2017

Funding

12860000

Employees

13 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

VistaPath Biosystems

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

vistapath.ai 1K+

Founded 2017 – Cambridge, United Kingdom

Funding

Estimated Funding

$10M+

Team (10+)

No team information available.

Company Description

Problem

Anatomic pathology labs face challenges with manual tissue grossing, which can lead to inconsistencies, inefficiencies, and potential quality control issues in sample preparation for diagnosis. The manual nature of the process is labor-intensive and prone to human error.

Solution

VistaPath Biosystems offers the Sentinel Platform, an end-to-end digital grossing solution that modernizes pathology labs by delivering higher quality, efficiency, and consistency across critical lab processes. The Sentinel Platform leverages computer vision, automation, and artificial intelligence to streamline the inspection, inking, and measurement of tissue samples. This AI-assisted histology platform enables more complex tissue grossing processes and delivers workflow improvements. The platform supports various specimen types, including excisions, and facilitates seamless remote approvals.

Features

AI-assisted grossing for improved accuracy and standardization

Computer vision for precise tissue analysis and measurement

Automated inking and imaging for enhanced sample preparation

Digital workflow for streamlined processes and remote approvals

Support for various specimen types, including excisions

Integration with LIS systems for seamless data management

Target Audience

The primary target audience includes commercial labs, hospitals, CROs, and life science labs seeking to modernize their pathology workflows and improve the quality and efficiency of tissue grossing.